Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Actions to Be Taken if Moisture Content Deviates from Acceptable Limits

Posted on By

SOP for Actions to Be Taken if Moisture Content Deviates from Acceptable Limits

Procedures for Addressing Deviations in Moisture Content Levels

1) Purpose

The purpose of this SOP is to outline the actions to be taken if the moisture content of capsules deviates from the acceptable limits, ensuring product quality and compliance.

2) Scope

This SOP applies to all capsules manufactured within the pharmaceutical facility, particularly those containing hygroscopic formulations.

3) Responsibilities

The Quality Control (QC) department is responsible for detecting deviations in moisture content and initiating corrective actions. The Production department is responsible for implementing the corrective actions.

See also  SOP for Visual Inspection

4) Procedure

  1. Detection of Deviations:
    1. Review the moisture content test results against the established acceptance criteria.
    2. If any result falls outside the acceptable range, document the deviation in the moisture content logbook.
  2. Initial Investigation:
    1. Notify the QC manager immediately upon detection of a deviation.
    2. Conduct a preliminary investigation to identify any obvious errors in the testing process, such as instrument malfunction or operator error.
  3. Root Cause Analysis:
    1. If no obvious error is found, perform a detailed root cause analysis to determine the underlying cause of the deviation.
    2. Examine factors such as raw material quality, manufacturing process parameters, and environmental conditions.
  4. Corrective Actions:
    1. Based on the root cause analysis, develop and implement corrective actions to address the
issue.
  • Examples of corrective actions include adjusting manufacturing parameters, retraining operators, and improving raw material inspection procedures.
  • Retesting:
    1. After implementing corrective actions, retest the affected batch of capsules to confirm that the moisture content meets the specified criteria.
    2. Document the retest results and compare them to the original deviation results.
  • Documentation and Reporting:
    1. Document all findings, corrective actions, and retest results in the moisture content logbook and the deviation report.
    2. Submit a final report summarizing the investigation and corrective actions to the QC manager for approval.
  • Preventive Actions:
    1. Review the deviation incident and identify preventive actions to avoid recurrence.
    2. Update SOPs, training materials, and process controls as necessary to incorporate the preventive actions.
  • 5) Abbreviations, if any

    QC: Quality Control

    6) Documents, if any

    Moisture Content Logbook, Deviation Reports, Corrective Action Records

    7) Reference, if any

    Relevant regulatory guidelines such as ICH Q7 and FDA Guidance for Industry

    8) SOP Version

    Version 1.0

    See also  SOP for Sampling and Retention of Samples
    Capsule Formulation Tags:Capsule Batch Record, Capsule Blending, Capsule Cleaning Validation, Capsule Coating, Capsule Deviation Investigation, Capsule Dosage Form, Capsule Encapsulation, Capsule Equipment Qualification, Capsule Filling, Capsule Formulation SOP, Capsule Inspection Procedure, Capsule Integrity, Capsule Manufacturing, Capsule Mixing, Capsule Polishing, Capsule Production, Capsule Quality Control, Capsule Sampling, Capsule Shell Inspection, Capsule Weight Check

    Post navigation

    Previous Post: Injectables: SOP for Water for Injection (WFI) Generation
    Next Post: SOP for Visually Inspecting Capsules for Defects

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version